Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2017

Open Access 01-12-2017 | Research

Expression of factors involved in apoptosis and cell survival is correlated with enzymes synthesizing lysophosphatidic acid and its receptors in granulosa cells originating from different types of bovine ovarian follicles

Published in: Reproductive Biology and Endocrinology | Issue 1/2017

Login to get access

Abstract

Background

Lysophosphatidic acid (LPA) regulates reproductive processes in the cow. Ovarian granulosa cells play a pivotal role in follicle growth and development. Nevertheless, the role of LPA in the local regulation of granulosa cell function in different follicle categories in the bovine ovary has not been investigated.

Methods

Ovarian follicles were divided into healthy, transitional and atretic categories. The expression levels of AX, PLA2, LPARs and factors involved in apoptosis and cell survival processes in granulosa cells in different types of follicles were measured by real-time PCR. The correlations between the expression levels of AX, PLA2, LPARs and the examined factors were measured. The immunolocalization of AX, PLA2 and LPARs in different ovarian follicles was examined by immunohistochemistry. Statistical analyses were conducted in GraphPad using a one-way ANOVA followed by the Kruskal-Wallis multiple comparison test or a correlation analysis followed by Pearson’s test.

Results

The expression levels of AX, PLA2 and LPARs, with the major role of LPAR2 and PLA2, were found in the granulosa cells originating from different follicle types. The expression levels of the factors involved in cell apoptosis (TNFα and its receptors, FAS, FASL, CASP3, CASP8, β-glycan, and DRAK2) were significantly higher in the granulosa cells of the atretic follicles compared to the healthy follicles. A number of correlations between LPARs, AX, PLA2 and factors associated with apoptosis were observed in the atretic but not in the healthy follicles. A greater expression of the factors involved in differentiation and proliferation in the granulosa cells (DICE1 and SOX2) was found in the healthy follicles in comparison with the atretic. A number of correlations between LPARs, AX, PLA2 and the factors associated with cell survival were observed in the healthy but not in the atretic follicles.

Conclusions

Granulosa cells are the target of LPA action and the source of LPA synthesis in the bovine ovarian follicle. We suggest that the participation of LPA in apoptosis in the atretic follicles mainly occurs through the regulation of TNF-α-dependent and caspase-induced pathways. In the transitional follicles, LPA might influence the inhibins to shift the balance between the number of healthy and atretic follicles. In the healthy follicle type, LPA, acting via LPAR1, might regulate MCL1 and estradiol-stimulating ERβ mRNA expression, leading to the stimulation of anti-apoptotic processes in the granulosa cells and their differentiation and proliferation.
Appendix
Available only for authorised users
Literature
1.
2.
Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reproduction. 2010;140:489–504.CrossRefPubMed
3.
Grimes RW, Ireland JJ. Relationship of macroscopic appearance of the surface of bovine ovarian follicles concentrations of steroids in follicular fluid, and maturation of oocytes in vitro. Biol Reprod. 1986;35:725–32.CrossRefPubMed
4.
Ginther OJ, Kastelic JP, Knopf L. Composition and characteristics of follicular waves during the bovine estrous cycle. Anim Reprod Sci. 1989;20:187–200.CrossRef
5.
6.
Tilly JL, Kowalski KI, Jahnson AL, Hsueh AJW. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology. 1991;129:2799–801.CrossRefPubMed
7.
Jiang JY, Cheung CKM, Wang YF, Tsang BK. Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia. Front Biosci. 2003;8:222–37.CrossRef
8.
Inoue N, Matsuda F, Goto Y, Manabe N. Role of cell-death ligan-receptor system of granulosa cells in selective follicular atresia in porcine ovary. J Reprod Dev. 2011;57:169–75.CrossRefPubMed
9.
Matsuda F, Inoue N, Manabe N, Ohkura S. Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells. J Rep Dev. 2012;58:44–50.CrossRef
10.
Fortune JE, Cushman RA, Wahl CM, Kito S. The primary to primordial follicle transition. Mol Cell Endocrinol. 2000;163:53–60.CrossRefPubMed
11.
Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction. 2001;121:503–12.CrossRefPubMed
12.
Ireland JJ, Roche JF. Development of nonovulatory antral follicles in heifers: changes in steroids in follicular fluid and receptors for gonadotropins. Endocrinology. 1983;112:150–6.CrossRefPubMed
13.
Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol. 2002;64:69–92.CrossRefPubMed
14.
Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-β superfamily in the intraovarian regulation of follicular development. Hum Reprod Update. 2005;11:143–60.CrossRefPubMed
15.
Boruszewska D, Sinderewicz E, Kowalczyk-Zieba I, Skarzynski DJ, Woclawek-Potocka I. Influence of lysophosphatidic acid on estradiol production and follicle stimulating hormone action in bovine granulosa cells. Reprod Biol. 2013;13:344–344.CrossRefPubMed
16.
Moolenaar WH. Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res. 1999;253:230–8.CrossRefPubMed
17.
Tigyi G, Parrill AL. Molecular mechanisms of lysophosphatidic acid action. Prog Lipid Res. 2003;42:498–526.CrossRefPubMed
18.
Gesta S, Simon MF, Rey A, Sibrac D, Girard A, Lafontan M, Valet P, Saulnier-Blache JS. Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis. J Lipid Res. 2002;43:904–10.PubMedPubMedCentral
19.
Kowalczyk-Zieba I, Boruszewska D, Saulnier-Blache JS, Lopes Da Costa L, Jankowska K, Skarzynski DJ, Woclawek-Potocka I. Lysophosphatidic acid action in the bovine corpus luteum -an in vitro study. J Reprod Dev. 2012;58:661–71.CrossRefPubMed
20.
Eder AM, Sasagawa T, Mao M, Aoki J, Mills GB. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Cancer Res. 2000;6:2482–91.PubMed
21.
Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, Kishimoto T, Mizuno K, Saku K, Taguchi R, Arai H. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem. 2002;277:48737–44.CrossRefPubMed
22.
Hausmann J, Perrakis A, Moolenaar WH. Structure-function relationships of autotaxin, a secreted lysophospholipase D. Adv Biol Regul. 2013;53:112–7.CrossRefPubMed
23.
Bandoh M, Aoki J, Hosono H, Kobayashii S, Murakami-Murofushii K, Arai H, Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem. 1999;274:27776–85.CrossRefPubMed
24.
Im DS, Heise C, Harding M, George S, Theodorescu D, Lynch K. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Mol Pharmacol. 2000;57:753–9.PubMed
25.
Noguchi K, Ishii S, Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem. 2003;278:25600–6.CrossRefPubMed
26.
Fukushima N, Weiner JA, Kaushal D, Contos JJ, Rehen SK, Kingsbury MA, Kim KY, Chun J. Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol Cell Neurosci. 2002;2:271–82.CrossRef
27.
Kim KS, Sengupta S, Berk M, Kwak YG, Escobar PF, Belinson J, Mok SC, Xu Y. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. 2006;66:7983–90.CrossRefPubMed
28.
Sui Y, Yang Y, Wang J, Li Y, Ma H, Cai H, Liu X, Zhang Y, Wang S, Li Z, Zhang X, Wang J, Liu R, Yan Y, Xue C, Shi X, Tan L, Ren J. Lysophosphatidic acid inhibits apoptosis induced by Cisplatin in cervical cancer cells. Biomed Res Int. 2015;2015:598386.CrossRefPubMedPubMedCentral
29.
Pustilnik TB, Estrella V, Wiener JR, Mao M, Eder A, Watt MA, Bast RC Jr, Mills GB. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res. 1999;5:3704–10.PubMed
30.
Kang S, Han J, Song SY, Kim WS, Shin S, Kim JH, Ahn H, Jeong JH, Hwang SJ, Sung JH. Lysophosphatidic acid increases the proliferation and migration of adipose-derived stem cells via the generation of reactive oxygen species. Mol Med Rep. 2015;12:5203–10.CrossRefPubMed
31.
Yamashita H, Tripathi M, Jourquin J, Kam Y, Liu S, Weidow B, Quaranta V. Lysophosphatidic acid Upregulates Laminin-332 expression during A431 cell Colony dispersal. J Oncol. 2010;2010:107075.CrossRefPubMedPubMedCentral
32.
Davis BJ, Lennard DE, Lee CA, Tiano HF, Morham SG, Wetsel WC, Langenbach R. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. Endocrinology. 1999;140:2685–95.CrossRefPubMed
33.
Peters MW, Pursley JR, Smith GW. Inhibition of intrafollicular PGE2 synthesis and ovulation following ultrasound-mediated intrafollicular injection of the selective cyclooxygenase-2 inhibitor NS-398 in cattle. J Anim Sci. 2004;82:1656–62.CrossRefPubMed
34.
Woclawek-Potocka I, Kondraciuk K, Skarzynski DJ. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured Stromal endometrial cells through LPA1 receptor. Exp Biol Med. 2009b;234:986–93.CrossRef
35.
Woclawek-Potocka I, Komiyama J, Saulnier-Blache JS, Brzezicka E, Bah MM, Okuda K, Skarzynski DJ. Lysophosphatic acid modulates prostaglandin secretion in the bovine uterus. Reproduction 2009c;137: 95-105.
36.
Woclawek-Potocka I, Brzezicka E, Skarzynski DJ. Lysophosphatic acid differently modulates prostaglandin secretion in the bovine endometrial cells on the days 8-10 of estrous cycle and early pregnancy. J Reprod Dev. 2009a;55: 393-399.
37.
Boruszewska D, Sinderewicz E, Kowalczyk-Zieba I, Grycmacher K, Woclawek-Potocka I. The effect of lysophosphatidic acid during in vitro maturation of bovine cumulus-oocyte complexes: cumulus expansion, glucose metabolism and expression of genes involved in the ovulatory cascade, oocyte and blastocyst competence. Reprod Biol Endocrinol. 2015;16:13–44.
38.
Budnik LT, Brunswig-Spickenheier B, Mukhopadhyay AK. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca scells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway? Mol Endocrinol. 2003;17:1593–606.CrossRefPubMed
39.
Jensen J, Orntoft T. Normalization of real-time quantative PCR data: a model based variance estimation approach to identify genes suited for normalization – applied to bladder- and colon-cancer data-sets. Cancer Res. 2004;64:5245–50.CrossRefPubMed
40.
Hojo T, Al-Zi'abi MO, Komiyama J, Manabe N, Acosta TJ, Okuda K. Expression and localization of cFLIP, an anti-apoptotic factor, in the bovine corpus luteum. J Reprod Dev. 2010;56(2):230–5.CrossRefPubMed
41.
Kowalczyk-Zieba I, Boruszewska D, Sinderewicz E, Grycmacher K, Woclawek-Potocka I. Lysophosphatidic acid modulates prostaglandin signalling in bovine steroidogenic luteal cells. Prostaglan Other Lipid Mediat. 2015;121:218–26.CrossRef
42.
Sinderewicz E, Grycmacher K, Boruszewska D, Kowalczyk-Zięba I, Woclawek-Potocka I. Lysophosphatidic acid expression in theca cells depends on the type of bovine ovarian follicle. Reprod Domest Anim. 2016;52:28–34.CrossRefPubMed
43.
Boruszewska D, Torres AC, Kowalczyk-Zieba I, Diniz P, Batista M, Lopes-da-Costa L, Woclawek-Potocka I. The effect of lysophosphatidic acid during in vitro maturation of bovine oocytes: embryonic development and mRNA abundances of genes involved in apoptosis and oocyte competence. Mediat Inflamm. 2014;2014:670670.CrossRef
44.
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/FAS) signaling pathways. EMBO J. 1998;17:1675–87.CrossRefPubMedPubMedCentral
45.
Adams GP. Comparative patterns of follicle development and selection in ruminants. J Rep Fert. 1999;54:17–32.
46.
Hsu SY, Hsueh AJW. Hormonal regulation of apoptosis. An ovarian perspective. Trends Endocrinol Metab. 1997;8:207–13.CrossRefPubMed
47.
Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372–7.CrossRefPubMed
48.
Chen HL, Marcinkiewicz JL, Sancho-Tello M, Hunt JS, Terranova PF. Tumor necrosis factor-alpha gene expression in mouse oocytes and follicular cells. Biol Reprod. 1993;48:707–14.CrossRefPubMed
49.
Nakayama M, Manabe N, Inoue N, Matsui T, Miyamoto H. Changes in the expression of tumor necrosis factor (TNF) alpha, TNFalpha receptor (TNFR) 2, and TNFR-associated factor 2 in granulosa cells during atresia in pig ovaries. Biol Reprod. 2003;68:530–5.CrossRefPubMed
50.
Evans AC, Ireland JL, Winn ME, Lonergan P, Smith GW, Coussens PM, Ireland JJ. Identification of genes involved in apoptosis and dominant follicle development during follicular waves in cattle. Biol Reprod. 2004;70:1475–84.CrossRefPubMed
51.
Porter DA, Harman RM, Cowan RG, Quirk SM. Relationship of FAS ligand expression and atresia during bovine follicle development. Reproduction. 2001;121:561–6.CrossRefPubMed
52.
Kim J-M, Boone DL, Auyeung A, Tsang BK. Granulosa cell apoptosis induced at the penultimate stage of follicular development is associated with increased levels of FAS and FAS ligand in the rat ovary. Biol Reprod. 1998;58:1170–6.CrossRefPubMed
53.
Kondo H, Maruo T, Peng X, Mochizuki M. Immunological evidence for the expression of the FAS antigen in the infant and adult human ovary during follicular regression and atresia. J Clin Endocrinol Metab. 1996;81:2702–10.PubMed
54.
Guan S, Guo L, Zhang T, Zhu B, Wang X, Zhang C. Effects of gonadotropin on FAS and/or FASL expression and proliferation in rat ovary. Theriogenology. 2015;83:21–9.CrossRefPubMed
55.
Ilha GF, Rovani MT, Gasperin BG, Antoniazzi AQ, Gonçalves PB, Bordignon V, Duggavathi R. Lack of FSH support enhances LIF–STAT3 signaling in granulosa cells of atretic follicles in cattle. Reproduction. 2015;150:395–403.CrossRefPubMed
56.
Bilandzic M, Stenvers KL. Betaglycan: a multifunctional accessory. Mol Cell Endocrinol. 2001;339:180–9.CrossRef
57.
Glister C, Satchell L, Knight PG. Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonize the suppressive effect of BMPs on thecal androgen production. Reproduction. 2010;140:699–712.CrossRefPubMed
58.
Matsuda-Minehata F, Inoue N, Goto Y, Manabe N. The regulation of ovarian granulosa cell death by pro- and anti-apoptotic molecules. J Reprod Dev. 2006;52:695–705.CrossRefPubMed
59.
Nagaraja AK, Andreu-Vieyra C, Franco HL, Ma L, Chen R, Han DY, Zhu H, Agno JE, Gunaratne PH, DeMayo FJ, Matzuk MM. Deletion of dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol. 2008;22:2336–52.CrossRefPubMedPubMedCentral
60.
Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006;13:1097–101.CrossRefPubMed
61.
Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G. Down-regulation of dicer expression in ovarian cancer tissues. Clin Biochem. 2010;43:324–7.CrossRefPubMed
62.
Shao R, Norström A, Weijdegård B, Egecioglu E, Fernandez-Rodriguez J, Feng Y, Stener-Victorin E, Brännström M, Billig H. Distinct expression pattern of Dicer1 correlates with ovarian-derived steroid hormone receptor expression in human fallopian tubes during ovulation and the midsecretory phase. J Clin Endocrinol Metab. 2011;96:869–77.CrossRef
63.
Hong X, Luense LJ, McGinnis LK, Nothnick WB, Christenson LK. Dicer1 is essential for female fertility and normal development of the female reproductive system. Endocrinology. 2008;149:6207–12.CrossRefPubMedPubMedCentral
64.
Lei L, Jin S, Gonzalez G, Behringer RR, Woodruff TK. The regulatory role of dicer in folliculogenesis in mice. Mol Cell Endocrinol. 2010;315:63–73.CrossRefPubMed
65.
Abdelalim EM, Emara MM, Kolatkar PR. The SOX transcription factors as key players in pluripotent stem cells. Stem Cells Dev. 2014;23:2687–99.CrossRefPubMed
66.
Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG. MCL1 overexpression leads to higher viabilities and increased production of humanized monoclonal antibody in Chinese hamster ovary cells. Biotechnol Prog. 2009;25:1161–8.CrossRefPubMed
67.
Fernández-Marrero Y, Spinner S, Kaufmann T, Jost PJ. Survival control of malignant lymphocytes by anti-apoptotic MCL1. Leukemia. 2016;30:2152–9.CrossRefPubMed
68.
Shigemasa K, Katoh O, Shiroyama Y, Mihara S, Mukai K, Nagai N, Ohama K. Increased MCL1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res. 2002;93:542–50.CrossRefPubMed
69.
Leo CP, Hsu SY, Chun SY, Bae HW, Hsueh AJ. Characterization of the antiapoptotic BCL2 family member myeloid cell leukemia-1 (Mcl- 1) and the stimulation of its message by gonadotropins in the rat ovary. Endocrinology. 1999;140:5469–77.CrossRefPubMed
70.
Lea RG, Andrade LP, Rae MT, Hannah LT, Kyle CE, Murray JF, Rhind SM, Miller DW. Effects of maternal undernutrition during early pregnancy on apoptosis regulators in the ovine fetal ovary. Reproduction. 2006;131:113–24.CrossRefPubMed
71.
Mihm M, Austin EJ, Good TE, Ireland JL, Knight PG, Roche JF, Ireland AJ. Identification of potential intrafollicular factors involved in selection of dominant follicles in heifers. Biol Reprod. 2000;63:811–9.CrossRefPubMed
72.
Austin EJ, Mihm M, Evans ACO, Knight PG, Ireland JLH, Ireland JJ, Roche JF. Alterations in intrafollicular regulatory factors and apoptosis during selection of follicles in the first follicular wave of the bovine estrous cycle. Biol Reprod. 2001;64:839–48.CrossRefPubMed
73.
Richards JS. Perspective: the ovarian follicle—a perspective in 2001. Endocrinology. 2001;142:2184–93.CrossRefPubMed
Metadata
Title
Expression of factors involved in apoptosis and cell survival is correlated with enzymes synthesizing lysophosphatidic acid and its receptors in granulosa cells originating from different types of bovine ovarian follicles
Publication date
01-12-2017
Published in
Reproductive Biology and Endocrinology / Issue 1/2017
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-017-0287-9

Other articles of this Issue 1/2017

Reproductive Biology and Endocrinology 1/2017 Go to the issue

Research

Testis specific histone 2B is associated with sperm chromatin dynamics and bull fertility-a pilot study

Correction

Correction to: Expression of factors involved in apoptosis and cell survival is correlated with enzymes synthesizing lysophosphatidic acid and its receptors in granulosa cells originating from different types of bovine ovarian follicles

Research

The role of ACE2, angiotensin-(1–7) and Mas1 receptor axis in glucocorticoid-induced intrauterine growth restriction

Research

Induction of altered gene expression profiles in cultured bovine granulosa cells at high cell density

Research

Towards a better understanding of preimplantation genetic screening for aneuploidy: insights from a virtual trial for women under the age of 40 when transferring embryos one at a time

Research

Efficient vitrification of mouse embryos using the Kitasato Vitrification System as a novel vitrification device